HK1213186A1 - 用於肺部使用的高劑量左旋多巴膠囊 - Google Patents

用於肺部使用的高劑量左旋多巴膠囊

Info

Publication number
HK1213186A1
HK1213186A1 HK16101181.9A HK16101181A HK1213186A1 HK 1213186 A1 HK1213186 A1 HK 1213186A1 HK 16101181 A HK16101181 A HK 16101181A HK 1213186 A1 HK1213186 A1 HK 1213186A1
Authority
HK
Hong Kong
Prior art keywords
high dose
pulmonary use
capsules
dose levodopa
levodopa capsules
Prior art date
Application number
HK16101181.9A
Other languages
English (en)
Inventor
D Kee Kevin
D Penachio Ernest
Kamerkar Abhijit
M Lipp Michael
P Batycky Richard
Original Assignee
Civitas Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/679,245 external-priority patent/US8545878B1/en
Application filed by Civitas Therapeutics Inc filed Critical Civitas Therapeutics Inc
Publication of HK1213186A1 publication Critical patent/HK1213186A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074Filling capsules; Related operations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/04Methods of, or means for, filling the material into the containers or receptacles
    • B65B1/16Methods of, or means for, filling the material into the containers or receptacles by pneumatic means, e.g. by suction
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/20Reducing volume of filled material
    • B65B1/26Reducing volume of filled material by pneumatic means, e.g. suction
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/30Devices or methods for controlling or determining the quantity or quality or the material fed or filled
    • B65B1/36Devices or methods for controlling or determining the quantity or quality or the material fed or filled by volumetric devices or methods
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B63/00Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
    • B65B63/02Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for compressing or compacting articles or materials prior to wrapping or insertion in containers or receptacles
    • B65B63/028Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for compressing or compacting articles or materials prior to wrapping or insertion in containers or receptacles by pneumatic means
HK16101181.9A 2012-11-09 2016-02-02 用於肺部使用的高劑量左旋多巴膠囊 HK1213186A1 (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261724781P 2012-11-09 2012-11-09
US13/679,245 US8545878B1 (en) 2012-11-09 2012-11-16 Capsules containing high doses of levodopa for pulmonary use
US13/945,160 US8685442B1 (en) 2012-11-09 2013-07-18 Capsules containing high doses of levodopa for pulmonary use
US201361884319P 2013-09-30 2013-09-30
US201361884315P 2013-09-30 2013-09-30
US201361884436P 2013-09-30 2013-09-30
PCT/US2013/069102 WO2014074795A1 (en) 2012-11-09 2013-11-08 High dose levodopa capsules for pulmonary use

Publications (1)

Publication Number Publication Date
HK1213186A1 true HK1213186A1 (zh) 2016-06-30

Family

ID=50685169

Family Applications (5)

Application Number Title Priority Date Filing Date
HK16100777.1A HK1212884A1 (zh) 2012-11-09 2016-01-22 超低密度的肺部粉末
HK16101182.8A HK1213187A1 (zh) 2012-11-09 2016-02-02 超低密度的肺部粉末
HK16101181.9A HK1213186A1 (zh) 2012-11-09 2016-02-02 用於肺部使用的高劑量左旋多巴膠囊
HK16101648.6A HK1213535A1 (zh) 2012-11-09 2016-02-16 用粉末填充膠囊的劑量分配器
HK16102954.2A HK1214957A1 (zh) 2012-11-09 2016-03-15 用於肺部使用的高劑量左旋多巴膠囊

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK16100777.1A HK1212884A1 (zh) 2012-11-09 2016-01-22 超低密度的肺部粉末
HK16101182.8A HK1213187A1 (zh) 2012-11-09 2016-02-02 超低密度的肺部粉末

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK16101648.6A HK1213535A1 (zh) 2012-11-09 2016-02-16 用粉末填充膠囊的劑量分配器
HK16102954.2A HK1214957A1 (zh) 2012-11-09 2016-03-15 用於肺部使用的高劑量左旋多巴膠囊

Country Status (19)

Country Link
US (3) US9642812B2 (zh)
EP (5) EP3957301A1 (zh)
JP (6) JP6348501B2 (zh)
KR (6) KR102337781B1 (zh)
CN (4) CN104918607B (zh)
AU (6) AU2013342247C1 (zh)
BR (2) BR112015010601B1 (zh)
CA (3) CA2890454C (zh)
DK (1) DK2916821T3 (zh)
ES (2) ES2880271T3 (zh)
HK (5) HK1212884A1 (zh)
MX (3) MX2015005767A (zh)
NZ (4) NZ708684A (zh)
PL (1) PL2916821T3 (zh)
PT (1) PT2916821T (zh)
RU (2) RU2670987C2 (zh)
SG (5) SG11201503547TA (zh)
WO (3) WO2014074797A1 (zh)
ZA (2) ZA201504060B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
MA40910A (fr) * 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
CN108700448B (zh) * 2016-02-06 2020-08-04 德国翰辉包装机械有限责任公司 刺戳吸移管
ITUA20163077A1 (it) * 2016-05-02 2017-11-02 Mg 2 Srl Gruppo di alimentazione per il dosaggio di granuli, in particolare microgranuli, in capsule
GB2550961A (en) * 2016-06-03 2017-12-06 Res Center Pharmaceutical Engineering Gmbh Apparatus for dosing a solid material into at least one receptacle
CN106394953A (zh) * 2016-06-24 2017-02-15 湖南千山制药机械股份有限公司 真空灌装系统
WO2019060797A1 (en) 2017-09-22 2019-03-28 Teva Branded Pharmaceutical Products R&D, Inc. PROCESS FOR PRODUCING POWDERS FOR INHALING
WO2019067708A1 (en) 2017-09-27 2019-04-04 Teva Branded Pharmaceutical Products R&D, Inc. METHOD FOR DECREASING PARTICLE SIZE
PT3833964T (pt) 2018-08-07 2023-08-17 Norton Waterford Ltd Aplicação de espetroscopia de raman para o fabrico de pós de inalação
EP3608015B1 (de) * 2018-08-08 2021-10-06 Harro Höfliger Verpackungsmaschinen GmbH Pulverbereitstellungseinrichtung für einen pulverdosierer
CN108995838A (zh) * 2018-09-10 2018-12-14 江西克莱威纳米碳材料有限公司 一种粉体装罐系统
CN109178367B (zh) * 2018-10-15 2021-01-26 楚天科技股份有限公司 用于粉体分装的灌装头和灌装装置
CN110040519A (zh) * 2019-04-30 2019-07-23 裕东(中山)机械工程有限公司 一种定量气固两相流输送装置及定量输送系统
RU2716294C1 (ru) * 2019-10-04 2020-03-11 Владимир Александрович Трусов Двухванная отражательная печь для переплава алюминиевого лома
IT202000008962A1 (it) * 2020-04-24 2021-10-24 Romaco Srl Apparecchiatura per il riempimento di contenitori con un materiale in polvere
WO2022122012A1 (zh) * 2020-12-11 2022-06-16 江苏恒瑞医药股份有限公司 用于肺部递送的药物组合物

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540059A (en) * 1947-08-02 1951-01-30 American Cyanamid Co Method of and apparatus for measuring and filling powders volumetrically
US3656518A (en) * 1967-03-27 1972-04-18 Perry Ind Inc Method and apparatus for measuring and dispensing predetermined equal amounts of powdered material
US3847191A (en) * 1971-08-23 1974-11-12 T Aronson Means and methods for measuring and dispensing equal amounts of powdered material
IT1069354B (it) * 1976-03-05 1985-03-25 Zanasi Nigris Spa Perfezionamenti nei dosatori volume trici
IT1156553B (it) * 1982-03-03 1987-02-04 Mg 2 Spa Procedimento per prelevare una quantita' prefissata di polvere dall'interno di un recipiente rotante e per depositare tale quantita' all'interno di un fondello di un contenitore di forma qualsiasi e macchina ch attui tale procedimento
JPS59115201A (ja) * 1982-12-10 1984-07-03 武田薬品工業株式会社 粉粒体処理機における粉粒体のシール装置
IT1245757B (it) * 1991-01-15 1994-10-14 Mg 2 Spa Macchina per il dosaggio di prodotti farmaceutici in polvere.
US5111642A (en) * 1991-01-23 1992-05-12 Macofar S.P.A. Machine for the dosage of powders in capsules, in particular for the pharmaceutical industry
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5826633A (en) * 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
CA2252814A1 (en) * 1996-04-29 1997-11-06 Dura Pharmaceuticals, Inc. Methods of dry powder inhalation
US6652837B1 (en) * 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
AU5719798A (en) * 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040028735A1 (en) 1997-11-14 2004-02-12 Unchalee Kositprapa Pharmaceutical formulation
CN1423553A (zh) * 1998-04-09 2003-06-11 阿克西瓦有限公司 用于肺部给药的颗粒赋形剂
MA25590A1 (fr) * 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
IT1304779B1 (it) * 1998-12-03 2001-03-29 Ima Spa Dosatrice a disco ed a pestelli, a funzionamento intermittente,monogiostra, particolarmente adatta per il confezionamento di dosi
US6858199B1 (en) 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
US7252840B1 (en) 1999-08-25 2007-08-07 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
GB9926335D0 (en) * 1999-11-05 2000-01-12 Powderject Res Ltd Apparatus and method for dispensing small quantities of particles
GB2356386A (en) 1999-11-17 2001-05-23 Tagra Biotechnologies Ltd Microencapsulation
US20030180352A1 (en) 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB0014082D0 (en) * 2000-06-10 2000-08-02 Glaxo Group Ltd Method and apparatus for transferring a defined quantity of powder
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US20020122773A1 (en) * 2000-12-20 2002-09-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and dopamine agonists
EP1345629A2 (en) 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6848197B2 (en) 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
US7621300B2 (en) * 2001-04-20 2009-11-24 Glaxo Group Limited Metering method for particulate material
EP1397134A2 (en) 2001-05-25 2004-03-17 Boehringer Ingelheim Pharma GmbH & Co.KG Combination of a dopamine d2-receptor agonist and tiotropium or a derivative therof for treating obstructive airways
US6531153B2 (en) 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6767200B2 (en) * 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
PT1455755E (pt) 2001-11-20 2013-06-18 Civitas Therapeutics Inc Composições particuladas melhoradas para distribuição pulmonar
EP1487411B1 (en) 2002-03-20 2019-01-02 Civitas Therapeutics, Inc. Inhalable sustained therapeutic formulations
US7754242B2 (en) 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7008644B2 (en) 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
JP4897198B2 (ja) 2002-03-20 2012-03-14 アルカームズ,インコーポレイテッド 吸入装置で使用する穿孔手段
US20110123574A1 (en) * 2002-03-20 2011-05-26 Alkermes, Inc. Inhalable sustained therapeutic formulations
EP1531798B1 (en) 2002-03-20 2012-06-06 Civitas Therapeutics, Inc. Pulmonary delivery for levodopa
AU2003239433A1 (en) * 2002-05-13 2003-11-11 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
US6941980B2 (en) * 2002-06-27 2005-09-13 Nektar Therapeutics Apparatus and method for filling a receptacle with powder
US20040060265A1 (en) * 2002-06-27 2004-04-01 Nektar Therapeutics Controlling the flow of a powder
PT1531794T (pt) 2002-06-28 2017-09-14 Civitas Therapeutics Inc Epinefrina inalável
ITBO20020525A1 (it) * 2002-08-08 2004-02-09 Ima Spa Macchina opercolatrice.
SI1565258T1 (sl) * 2002-11-26 2012-04-30 Univ Gent Postopek in naprava za neprekinjeno mokro granulacijo materiala v prahu
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
EP1617820B1 (en) * 2003-04-14 2018-03-21 Vectura Limited Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
DE20309279U1 (de) * 2003-06-12 2004-10-21 Harro Höfliger Verpackungsmaschinen GmbH Filterkolbenvorrichtung zum Abfüllen von pulvrigem Schüttgut
US7134459B2 (en) * 2003-06-12 2006-11-14 Symyx Technologies, Inc. Methods and apparatus for mixing powdered samples
WO2004112702A2 (en) 2003-06-13 2004-12-29 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
EP1729724A4 (en) * 2003-12-31 2008-07-23 Cydex Inc INHALATION FORMULATION WITH SULFOALKYL ETHER GAMMA CYCLODEXTRIN AND CORTICOSTEROID
SE0401842D0 (sv) * 2004-07-12 2004-07-12 Dizlin Medical Design Ab Infusion and injection solution of levodopa
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
US20060216345A1 (en) 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
US20060222699A1 (en) 2005-03-29 2006-10-05 Jonathan Gilinski Flavored vegetarian cellulose capsule and methods for producing said capsule.
WO2007019229A1 (en) * 2005-08-05 2007-02-15 3M Innovative Properties Company Compositions exhibiting improved flowability
AR055106A1 (es) 2005-08-05 2007-08-08 Osmotica Pharmaceutical Argent Composicion farmaceutica solida de liberacion extendida que contiene carbidopa y levodopa
DE102005039765A1 (de) * 2005-08-23 2007-03-01 Robert Bosch Gmbh Sensiervorrichtung
GB0523576D0 (en) * 2005-11-18 2005-12-28 Theradeas Ltd Drug composition and its use in therapy
US20120128728A1 (en) * 2005-12-28 2012-05-24 Novartis Pharma Ag Compositions Comprising Amphotericin B
DE602005020334D1 (de) * 2005-12-29 2010-05-12 Mg2 Srl Vorrichtung zum Befüllen von Kapseln mit einem Produkt
CA2648280C (en) * 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US20080063722A1 (en) 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
EP3594248B1 (en) 2006-10-27 2021-08-04 Capsugel Belgium NV Hydroxypropyl methyl cellulose hard capsules and process of manufacture
EP2063867A2 (en) 2006-12-22 2009-06-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
WO2008156586A2 (en) 2007-06-12 2008-12-24 Alkermes, Inc. Inhalation device for powdered substances
PE20090907A1 (es) * 2007-07-21 2009-08-05 Boehringer Ingelheim Int Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
US8614255B2 (en) 2007-08-21 2013-12-24 Civitas Therapeutics, Inc. Pulmonary pharmaceutical formulations
GB2454480A (en) 2007-11-07 2009-05-13 Vectura Group Plc Pulmonary inhalation of levodopa containing compositions in the treatment of Parkinsons disease and other central nervous system disorders
DK2570147T3 (da) * 2008-06-13 2018-01-29 Mannkind Corp Tørpulverinhalator og system til lægemiddelindgivelse
CN102119026A (zh) 2008-06-13 2011-07-06 葛兰素集团有限公司 羟丙基纤维素胶囊壳
US8485180B2 (en) * 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US20110268666A1 (en) 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
IT1390803B1 (it) * 2008-09-30 2011-10-19 Mg2 Srl Apparecchiatura per la dosatura di materiali pulverulenti o granulari in capsule o similari
US8399513B2 (en) 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
JP2012509922A (ja) * 2008-11-27 2012-04-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規粉末化結晶質吸入薬
BRPI1011721B1 (pt) * 2009-03-26 2021-11-16 Pulmatrix, Inc Formulações em pó seco inaláveis compreendendo sal de cátion de metal divalente e métodos para tratar doenças pulmonares
WO2010121323A1 (en) * 2009-04-24 2010-10-28 Iceutica Pty Ltd Method for the production of commercial nanoparticle and microparticle powders
IT1394027B1 (it) * 2009-05-11 2012-05-25 Mg 2 Srl Macchina per il riempimento di capsule con prodotti farmaceutici
US8359815B2 (en) * 2009-05-11 2013-01-29 Mg 2—S.R.L. Machine for filling capsules with pharmaceutical products
GB0918450D0 (en) * 2009-10-21 2009-12-09 Innovata Ltd Composition
RU2445119C2 (ru) * 2010-05-25 2012-03-20 Сергей Викторович Чепур Фармацевтическая композиция и способ ее ингаляционного введения
US20120164233A1 (en) 2010-07-30 2012-06-28 Ranbaxy Laboratories Limited Pulsatile release pharmaceutical formulation of dexlansoprazole
WO2012030664A1 (en) * 2010-08-30 2012-03-08 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
TW201304822A (zh) * 2010-11-15 2013-02-01 Vectura Ltd 組成物及用途
NZ708415A (en) 2012-10-22 2018-11-30 Civitas Therapeutics Inc Reducing inter-patient variability of levodopa plasma concentrations
KR20150102960A (ko) 2012-10-22 2015-09-09 키비타스 테라퓨틱스, 인코포레이티드. 파킨슨병의 빠른 경감을 위한 레보도파 제형
BR112015010601B1 (pt) 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
US8545878B1 (en) 2012-11-09 2013-10-01 Civitas Therapeutics, Inc. Capsules containing high doses of levodopa for pulmonary use
US20170296498A1 (en) 2014-04-21 2017-10-19 Civitas Therapeutics, Inc. Rapid Relief of Motor Fluctuations in Parkinson's Disease

Also Published As

Publication number Publication date
KR102257164B1 (ko) 2021-05-26
US9642812B2 (en) 2017-05-09
EP2916826A4 (en) 2016-07-27
KR102389785B1 (ko) 2022-04-22
RU2015121092A (ru) 2017-01-10
WO2014074795A1 (en) 2014-05-15
HK1214957A1 (zh) 2016-08-12
KR20210062730A (ko) 2021-05-31
DK2916821T3 (da) 2021-01-18
JP6721629B2 (ja) 2020-07-15
SG11201503547TA (en) 2015-06-29
US20180036253A1 (en) 2018-02-08
BR112015010603A2 (pt) 2017-08-15
HK1213535A1 (zh) 2016-07-08
HK1213187A1 (zh) 2016-06-30
CA2890454C (en) 2020-10-27
RU2015121091A (ru) 2017-01-10
EP2916821B1 (en) 2020-10-21
CN109106697B (zh) 2022-02-15
AU2017279626B2 (en) 2019-09-12
CN104918607B (zh) 2018-10-12
AU2013342248B2 (en) 2018-05-31
ES2844153T3 (es) 2021-07-21
KR20230116102A (ko) 2023-08-03
WO2014074796A1 (en) 2014-05-15
CN109106697A (zh) 2019-01-01
SG10202109328QA (en) 2021-10-28
RU2670987C2 (ru) 2018-10-29
MX2015005767A (es) 2015-11-25
JP6347786B2 (ja) 2018-06-27
BR112015010603B1 (pt) 2022-10-11
US20150342890A1 (en) 2015-12-03
AU2018222983B2 (en) 2020-02-27
RU2676093C2 (ru) 2018-12-26
JP2015536197A (ja) 2015-12-21
SG10201707103SA (en) 2017-10-30
NZ733459A (en) 2019-09-27
CA2890454A1 (en) 2014-05-15
ZA201504058B (en) 2016-11-30
EP2925611A4 (en) 2016-09-07
CA2890459C (en) 2022-08-23
AU2013342247C1 (en) 2017-12-21
NZ747376A (en) 2020-02-28
EP3957301A1 (en) 2022-02-23
CN104918607A (zh) 2015-09-16
AU2013342246B2 (en) 2018-03-29
ES2880271T3 (es) 2021-11-24
KR102337781B1 (ko) 2021-12-09
US9539211B2 (en) 2017-01-10
WO2014074797A1 (en) 2014-05-15
US10238607B2 (en) 2019-03-26
KR20220054703A (ko) 2022-05-03
MX2020012506A (es) 2021-02-15
PT2916821T (pt) 2021-01-21
KR20150108816A (ko) 2015-09-30
JP6836834B2 (ja) 2021-03-03
EP2925611B1 (en) 2022-03-09
KR20210152020A (ko) 2021-12-14
JP2018162258A (ja) 2018-10-18
AU2013342247B2 (en) 2017-09-21
PL2916821T3 (pl) 2021-07-05
NZ708682A (en) 2017-11-24
JP6348501B2 (ja) 2018-06-27
WO2014074797A8 (en) 2014-06-26
ZA201504060B (en) 2016-04-28
AU2018204674A1 (en) 2018-07-12
AU2017279626A1 (en) 2018-01-18
EP2925611A1 (en) 2015-10-07
CA2890459A1 (en) 2014-05-15
BR112015010601A2 (zh) 2017-08-15
CA2890451A1 (en) 2014-05-15
JP6669808B2 (ja) 2020-03-18
EP2916821A1 (en) 2015-09-16
AU2018222983A1 (en) 2018-09-20
CN105120843A (zh) 2015-12-02
JP2015536989A (ja) 2015-12-24
AU2013342248A1 (en) 2015-07-02
BR112015010601A8 (pt) 2018-01-16
CN110833539A (zh) 2020-02-25
MX371008B (es) 2020-01-13
JP2019213867A (ja) 2019-12-19
HK1212884A1 (zh) 2016-06-24
NZ708684A (en) 2019-09-27
AU2018204674B2 (en) 2019-09-19
AU2013342246A1 (en) 2015-07-02
CA2890451C (en) 2022-07-19
SG10201706465XA (en) 2017-09-28
AU2013342247A1 (en) 2015-07-02
JP2018150355A (ja) 2018-09-27
KR20150110480A (ko) 2015-10-02
EP2916821A4 (en) 2016-08-03
EP2916826B1 (en) 2021-04-28
US20150342885A1 (en) 2015-12-03
EP2916826A1 (en) 2015-09-16
EP3815679A1 (en) 2021-05-05
SG11201503543PA (en) 2015-06-29
JP2015536988A (ja) 2015-12-24
BR112015010601B1 (pt) 2022-07-19
MX2015005768A (es) 2015-11-25

Similar Documents

Publication Publication Date Title
HK1214957A1 (zh) 用於肺部使用的高劑量左旋多巴膠囊
EP2913047A4 (en) SPECIFIC THERAPEUTIC AGENT OF PULMONARY DISEASE
ZA201502685B (en) Capsules
IL273076A (en) Solid dosage form
HK1208067A1 (zh) 小容器
GB201205164D0 (en) Pharmaceutical compounds
HK1210718A1 (zh) 抗白癬菌症外用液劑
GB201218012D0 (en) Dosage forms
HK1216619A1 (zh) 藥物化合物
SG11201406097SA (en) Capsule formulation
GB201202027D0 (en) Pharmaceutical compounds
EP2863894A4 (en) fenofibrate
EP2863890A4 (en) FORMULATION OF FENOFIBRATE
GB201220749D0 (en) Capsules
GB201202127D0 (en) Supramolecular capsules
AU343663S (en) Portion capsule
GB201219236D0 (en) Pharmaceutical compounds
GB201214121D0 (en) Pharmaceutical compounds
GB201213519D0 (en) Pharmaceutical compounds
GB201203253D0 (en) Pharmaceutical compounds